Your browser doesn't support javascript.
loading
Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia.
Khanna, Vishesh; Pierce, Scott T; Dao, Kim-Hien T; Tognon, Cristina E; Hunt, David E; Junio, Brian; Tyner, Jeffrey W; Druker, Brian J.
Affiliation
  • Khanna V; Knight Cancer Institute, Oregon Health & Science University ; Howard Hughes Medical Institute Medical Research Fellows Program, Howard Hughes Medical Institute ; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University.
  • Pierce ST; Department of Hematology/Oncology, Saint Joseph Hospital.
  • Dao KH; Knight Cancer Institute, Oregon Health & Science University.
  • Tognon CE; Knight Cancer Institute, Oregon Health & Science University.
  • Hunt DE; Saint Joseph Hospital Laboratory, Saint Joseph Hospital.
  • Junio B; Knight Cancer Institute, Oregon Health & Science University.
  • Tyner JW; Knight Cancer Institute, Oregon Health & Science University.
  • Druker BJ; Knight Cancer Institute, Oregon Health & Science University ; Howard Hughes Medical Institute Investigator Program, Howard Hughes Medical Institute ; Division of Hematology & Medical Oncology, Oregon Health & Science University ; Department of Cell, Developmental & Cancer Biology, Or
Cureus ; 7(12): e414, 2015 Dec 17.
Article in En | MEDLINE | ID: mdl-26870618
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2015 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2015 Document type: Article Country of publication: Estados Unidos